Clinical Trials Directory

Trials / Completed

CompletedNCT03043690

A Pooled Analysis of the Data From Two Studies of Ammonium Succinate for Menopausal Symptoms

Clinical Efficacy of an Ammonium Succinate-based Dietary Supplement in Women With Menopausal Symptoms: a Pooled Analysis of the Data From Two Randomized, Multicenter, Double-blinded Placebo-controlled Clinical Trials.

Status
Completed
Phase
Study type
Observational
Enrollment
227 (actual)
Sponsor
I.M. Sechenov First Moscow State Medical University · Academic / Other
Sex
Female
Age
42 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This study is a pooled statistical analysis of the data from 2 studies concerning efficacy of ammonium-succinate based dietary supplement. In both studies group 1 took the ammonium-succinate based dietary supplement and the group 2 took placebo.

Detailed description

Both studies were conducted previously and were randomized, double-blind and placebo-controlled. They followed very similar protocols, were of nearly identical design, had common inclusion and exclusion criteria. Both studies achieved statistical significance for ammonium succinate-based dietary supplement on most of pre-specified endpoints of Greene Climacteric Scale symptoms severity reduction at week 12. Nevertheless, some minor variation in the patient population, both within the studies (e.g., between different centres, as well as seasonal variability) and between the studies can be expected. Naturally occuring estrogen deficiency over the course of the menopausal transition and postmenopause causes hot flushes and other psychosomatic and vasomotor symptoms. Menopausal hormone therapy is a method of choice, however in many cases it is contraindicated or unacceptable for other reasons. Many alternatives exist, generally acting via estrogen receptors (ER). The dietary supplement tested in the aforementioned studies contains ammonium succinate, which does not bind to ER, instead acting by supporting the Krebs cycle. It does not have phytoestrogenic ingredients.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAmmonium succinate2 capsules of ammonium succinate-based dietary supplement (one white, 200 mg, and one orange, 200 mg), once a day, in the morning with a meal, for 90 days.
OTHERPlacebo2 capsules of ammonium succinate-based dietary supplement (one white, 200 mg, and one orange, 200 mg), once a day, in the morning with a meal, for 90 days.

Timeline

Start date
2017-02-11
Primary completion
2017-05-03
Completion
2017-05-30
First posted
2017-02-06
Last updated
2017-10-20

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT03043690. Inclusion in this directory is not an endorsement.